Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
This report aims to provide a comprehensive presentation of the global market for Pituitary Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pituitary Cancer. This report contains market size and forecasts of Pituitary Cancer in global, including the following market information:
Global Pituitary Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pituitary Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
We surveyed the Pituitary Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pituitary Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pituitary Cancer Market Segment Percentages, by Type, 2022 (%)
Blood Tests
Urine Test
Brain Imaging
Vision Testing
Global Pituitary Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pituitary Cancer Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Diagnostic Centers
Research Institutes
Global Pituitary Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pituitary Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pituitary Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pituitary Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Trinity Biotech
Salzman
Genentech
Sigma-Aldrich
Varian Medical Systems
Elekta
Accuray Incorporated
Ion Beam Applications
Nordion
C. R. Bard
Isoray Medical
RaySearch Laboratories
Mevion Medical Systems
Mitsubishi Electric
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pituitary Cancer, market overview.
Chapter 2: Global Pituitary Cancer market size in revenue.
Chapter 3: Detailed analysis of Pituitary Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pituitary Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pituitary Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pituitary Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pituitary Cancer Overall Market Size
2.1 Global Pituitary Cancer Market Size: 2022 VS 2029
2.2 Global Pituitary Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pituitary Cancer Players in Global Market
3.2 Top Global Pituitary Cancer Companies Ranked by Revenue
3.3 Global Pituitary Cancer Revenue by Companies
3.4 Top 3 and Top 5 Pituitary Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pituitary Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pituitary Cancer Players in Global Market
3.6.1 List of Global Tier 1 Pituitary Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Pituitary Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pituitary Cancer Market Size Markets, 2022 & 2029
4.1.2 Blood Tests
4.1.3 Urine Test
4.1.4 Brain Imaging
4.1.5 Vision Testing
4.2 By Type - Global Pituitary Cancer Revenue & Forecasts
4.2.1 By Type - Global Pituitary Cancer Revenue, 2018-2023
4.2.2 By Type - Global Pituitary Cancer Revenue, 2024-2029
4.2.3 By Type - Global Pituitary Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pituitary Cancer Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Research Institutes
5.2 By Application - Global Pituitary Cancer Revenue & Forecasts
5.2.1 By Application - Global Pituitary Cancer Revenue, 2018-2023
5.2.2 By Application - Global Pituitary Cancer Revenue, 2024-2029
5.2.3 By Application - Global Pituitary Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pituitary Cancer Market Size, 2022 & 2029
6.2 By Region - Global Pituitary Cancer Revenue & Forecasts
6.2.1 By Region - Global Pituitary Cancer Revenue, 2018-2023
6.2.2 By Region - Global Pituitary Cancer Revenue, 2024-2029
6.2.3 By Region - Global Pituitary Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pituitary Cancer Revenue, 2018-2029
6.3.2 US Pituitary Cancer Market Size, 2018-2029
6.3.3 Canada Pituitary Cancer Market Size, 2018-2029
6.3.4 Mexico Pituitary Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pituitary Cancer Revenue, 2018-2029
6.4.2 Germany Pituitary Cancer Market Size, 2018-2029
6.4.3 France Pituitary Cancer Market Size, 2018-2029
6.4.4 U.K. Pituitary Cancer Market Size, 2018-2029
6.4.5 Italy Pituitary Cancer Market Size, 2018-2029
6.4.6 Russia Pituitary Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Pituitary Cancer Market Size, 2018-2029
6.4.8 Benelux Pituitary Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pituitary Cancer Revenue, 2018-2029
6.5.2 China Pituitary Cancer Market Size, 2018-2029
6.5.3 Japan Pituitary Cancer Market Size, 2018-2029
6.5.4 South Korea Pituitary Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Pituitary Cancer Market Size, 2018-2029
6.5.6 India Pituitary Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pituitary Cancer Revenue, 2018-2029
6.6.2 Brazil Pituitary Cancer Market Size, 2018-2029
6.6.3 Argentina Pituitary Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pituitary Cancer Revenue, 2018-2029
6.7.2 Turkey Pituitary Cancer Market Size, 2018-2029
6.7.3 Israel Pituitary Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Pituitary Cancer Market Size, 2018-2029
6.7.5 UAE Pituitary Cancer Market Size, 2018-2029
7 Pituitary Cancer Companies Profiles
7.1 Trinity Biotech
7.1.1 Trinity Biotech Company Summary
7.1.2 Trinity Biotech Business Overview
7.1.3 Trinity Biotech Pituitary Cancer Major Product Offerings
7.1.4 Trinity Biotech Pituitary Cancer Revenue in Global Market (2018-2023)
7.1.5 Trinity Biotech Key News & Latest Developments
7.2 Salzman
7.2.1 Salzman Company Summary
7.2.2 Salzman Business Overview
7.2.3 Salzman Pituitary Cancer Major Product Offerings
7.2.4 Salzman Pituitary Cancer Revenue in Global Market (2018-2023)
7.2.5 Salzman Key News & Latest Developments
7.3 Genentech
7.3.1 Genentech Company Summary
7.3.2 Genentech Business Overview
7.3.3 Genentech Pituitary Cancer Major Product Offerings
7.3.4 Genentech Pituitary Cancer Revenue in Global Market (2018-2023)
7.3.5 Genentech Key News & Latest Developments
7.4 Sigma-Aldrich
7.4.1 Sigma-Aldrich Company Summary
7.4.2 Sigma-Aldrich Business Overview
7.4.3 Sigma-Aldrich Pituitary Cancer Major Product Offerings
7.4.4 Sigma-Aldrich Pituitary Cancer Revenue in Global Market (2018-2023)
7.4.5 Sigma-Aldrich Key News & Latest Developments
7.5 Varian Medical Systems
7.5.1 Varian Medical Systems Company Summary
7.5.2 Varian Medical Systems Business Overview
7.5.3 Varian Medical Systems Pituitary Cancer Major Product Offerings
7.5.4 Varian Medical Systems Pituitary Cancer Revenue in Global Market (2018-2023)
7.5.5 Varian Medical Systems Key News & Latest Developments
7.6 Elekta
7.6.1 Elekta Company Summary
7.6.2 Elekta Business Overview
7.6.3 Elekta Pituitary Cancer Major Product Offerings
7.6.4 Elekta Pituitary Cancer Revenue in Global Market (2018-2023)
7.6.5 Elekta Key News & Latest Developments
7.7 Accuray Incorporated
7.7.1 Accuray Incorporated Company Summary
7.7.2 Accuray Incorporated Business Overview
7.7.3 Accuray Incorporated Pituitary Cancer Major Product Offerings
7.7.4 Accuray Incorporated Pituitary Cancer Revenue in Global Market (2018-2023)
7.7.5 Accuray Incorporated Key News & Latest Developments
7.8 Ion Beam Applications
7.8.1 Ion Beam Applications Company Summary
7.8.2 Ion Beam Applications Business Overview
7.8.3 Ion Beam Applications Pituitary Cancer Major Product Offerings
7.8.4 Ion Beam Applications Pituitary Cancer Revenue in Global Market (2018-2023)
7.8.5 Ion Beam Applications Key News & Latest Developments
7.9 Nordion
7.9.1 Nordion Company Summary
7.9.2 Nordion Business Overview
7.9.3 Nordion Pituitary Cancer Major Product Offerings
7.9.4 Nordion Pituitary Cancer Revenue in Global Market (2018-2023)
7.9.5 Nordion Key News & Latest Developments
7.10 C. R. Bard
7.10.1 C. R. Bard Company Summary
7.10.2 C. R. Bard Business Overview
7.10.3 C. R. Bard Pituitary Cancer Major Product Offerings
7.10.4 C. R. Bard Pituitary Cancer Revenue in Global Market (2018-2023)
7.10.5 C. R. Bard Key News & Latest Developments
7.11 Isoray Medical
7.11.1 Isoray Medical Company Summary
7.11.2 Isoray Medical Business Overview
7.11.3 Isoray Medical Pituitary Cancer Major Product Offerings
7.11.4 Isoray Medical Pituitary Cancer Revenue in Global Market (2018-2023)
7.11.5 Isoray Medical Key News & Latest Developments
7.12 RaySearch Laboratories
7.12.1 RaySearch Laboratories Company Summary
7.12.2 RaySearch Laboratories Business Overview
7.12.3 RaySearch Laboratories Pituitary Cancer Major Product Offerings
7.12.4 RaySearch Laboratories Pituitary Cancer Revenue in Global Market (2018-2023)
7.12.5 RaySearch Laboratories Key News & Latest Developments
7.13 Mevion Medical Systems
7.13.1 Mevion Medical Systems Company Summary
7.13.2 Mevion Medical Systems Business Overview
7.13.3 Mevion Medical Systems Pituitary Cancer Major Product Offerings
7.13.4 Mevion Medical Systems Pituitary Cancer Revenue in Global Market (2018-2023)
7.13.5 Mevion Medical Systems Key News & Latest Developments
7.14 Mitsubishi Electric
7.14.1 Mitsubishi Electric Company Summary
7.14.2 Mitsubishi Electric Business Overview
7.14.3 Mitsubishi Electric Pituitary Cancer Major Product Offerings
7.14.4 Mitsubishi Electric Pituitary Cancer Revenue in Global Market (2018-2023)
7.14.5 Mitsubishi Electric Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pituitary Cancer Market Opportunities & Trends in Global Market
Table 2. Pituitary Cancer Market Drivers in Global Market
Table 3. Pituitary Cancer Market Restraints in Global Market
Table 4. Key Players of Pituitary Cancer in Global Market
Table 5. Top Pituitary Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pituitary Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pituitary Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pituitary Cancer Product Type
Table 9. List of Global Tier 1 Pituitary Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pituitary Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pituitary Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pituitary Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pituitary Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pituitary Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pituitary Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pituitary Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pituitary Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pituitary Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pituitary Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pituitary Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pituitary Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pituitary Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pituitary Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pituitary Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pituitary Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pituitary Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pituitary Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pituitary Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pituitary Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Trinity Biotech Company Summary
Table 31. Trinity Biotech Pituitary Cancer Product Offerings
Table 32. Trinity Biotech Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Trinity Biotech Key News & Latest Developments
Table 34. Salzman Company Summary
Table 35. Salzman Pituitary Cancer Product Offerings
Table 36. Salzman Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Salzman Key News & Latest Developments
Table 38. Genentech Company Summary
Table 39. Genentech Pituitary Cancer Product Offerings
Table 40. Genentech Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Genentech Key News & Latest Developments
Table 42. Sigma-Aldrich Company Summary
Table 43. Sigma-Aldrich Pituitary Cancer Product Offerings
Table 44. Sigma-Aldrich Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Sigma-Aldrich Key News & Latest Developments
Table 46. Varian Medical Systems Company Summary
Table 47. Varian Medical Systems Pituitary Cancer Product Offerings
Table 48. Varian Medical Systems Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Varian Medical Systems Key News & Latest Developments
Table 50. Elekta Company Summary
Table 51. Elekta Pituitary Cancer Product Offerings
Table 52. Elekta Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Elekta Key News & Latest Developments
Table 54. Accuray Incorporated Company Summary
Table 55. Accuray Incorporated Pituitary Cancer Product Offerings
Table 56. Accuray Incorporated Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Accuray Incorporated Key News & Latest Developments
Table 58. Ion Beam Applications Company Summary
Table 59. Ion Beam Applications Pituitary Cancer Product Offerings
Table 60. Ion Beam Applications Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Ion Beam Applications Key News & Latest Developments
Table 62. Nordion Company Summary
Table 63. Nordion Pituitary Cancer Product Offerings
Table 64. Nordion Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Nordion Key News & Latest Developments
Table 66. C. R. Bard Company Summary
Table 67. C. R. Bard Pituitary Cancer Product Offerings
Table 68. C. R. Bard Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. C. R. Bard Key News & Latest Developments
Table 70. Isoray Medical Company Summary
Table 71. Isoray Medical Pituitary Cancer Product Offerings
Table 72. Isoray Medical Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Isoray Medical Key News & Latest Developments
Table 74. RaySearch Laboratories Company Summary
Table 75. RaySearch Laboratories Pituitary Cancer Product Offerings
Table 76. RaySearch Laboratories Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 77. RaySearch Laboratories Key News & Latest Developments
Table 78. Mevion Medical Systems Company Summary
Table 79. Mevion Medical Systems Pituitary Cancer Product Offerings
Table 80. Mevion Medical Systems Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 81. Mevion Medical Systems Key News & Latest Developments
Table 82. Mitsubishi Electric Company Summary
Table 83. Mitsubishi Electric Pituitary Cancer Product Offerings
Table 84. Mitsubishi Electric Pituitary Cancer Revenue (US$, Mn) & (2018-2023)
Table 85. Mitsubishi Electric Key News & Latest Developments
List of Figures
Figure 1. Pituitary Cancer Segment by Type in 2022
Figure 2. Pituitary Cancer Segment by Application in 2022
Figure 3. Global Pituitary Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pituitary Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pituitary Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pituitary Cancer Revenue in 2022
Figure 8. By Type - Global Pituitary Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pituitary Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pituitary Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pituitary Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pituitary Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pituitary Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pituitary Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pituitary Cancer Revenue Market Share, 2018-2029
Figure 16. US Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pituitary Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pituitary Cancer Revenue Market Share, 2018-2029
Figure 28. China Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pituitary Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pituitary Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pituitary Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Trinity Biotech Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Salzman Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genentech Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sigma-Aldrich Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Varian Medical Systems Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Elekta Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Accuray Incorporated Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ion Beam Applications Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nordion Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. C. R. Bard Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Isoray Medical Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. RaySearch Laboratories Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Mevion Medical Systems Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Mitsubishi Electric Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
